A recent Indian Phase III randomized open-label study has demonstrated that Sun Pharma’s injectable semaglutide is ...
The FDA’s approval of the new weight loss pill Orforglipron marks a shift in the world of obesity treatment. The change may ...
Weekly subcutaneous gefurulimab delivered early is linked to lasting symptom improvement in patients with generalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results